2025-08-28 21:22:20
Latest Post
Himadri Speciality Chemical Ltd Secures ISCC PLUS Certification
HCLSoftware delivers Digital Independence with AI-Powered Sovereign Collaboration Solutions for Business-Critical Infrastructure
Dr. Agarwal's Health Care Limited and Dr. Agarwal's Eye Hospital Limited announce Merger
SAMHI signs agreement to Lease for ~260-room Mid-Scale Hotel in Hyderabad's Financial District
Rail Vikas Nigam Ltd signs JV agreement with Texmaco Rail & Engineering Ltd
Stock Report
Astrazeneca Pharma India Ltd Q4FY21 net profit up at Rs. 27.27 crore
Posted On : 2021-05-25 16:48:02( TIMEZONE : IST )
ASTRAZENECA PHARMA INDIA LTD. has reported financial results for the period ended March 31, 2021.
Financial Results (Q4 FY20-21) - QoQ Comparison
The company has reported total income of Rs.212.80 crores during the period ended March 31, 2021 as compared to Rs.203.18 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.27.27 crores for the period ended March 31, 2021 as against net profit / (loss) of Rs.21.05 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.10.91 for the period ended March 31, 2021 as compared to Rs.8.42 for the period ended December 31, 2020.
| Financials | Q4 FY20-21 | Q3 FY20-21 | % Change |
| Total Income | ₹ 212.80 crs | ₹ 203.18 crs |  4.73% |
| Net Profit | ₹ 27.27 crs | ₹ 21.05 crs | 29.55% |
| EPS | ₹ 10.91 | ₹ 8.42 | 29.57% |
Financial Results (Q4 FY20-21) - YoY Comparison
The company has reported total income of Rs.212.80 crores during the period ended March 31, 2021 as compared to Rs.198.27 crores during the period ended March 31, 2020.
The company has posted net profit / (loss) of Rs.27.27 crores for the period ended March 31, 2021 as against net profit / (loss) of Rs.9.57 crores for the period ended March 31, 2020.
The company has reported EPS of Rs.10.91 for the period ended March 31, 2021 as compared to Rs.3.83 for the period ended March 31, 2020.
| Financials | Q4 FY20-21 | Q4 FY19-20 | % Change |
| Total Income | ₹ 212.80 crs | ₹ 198.27 crs | 7.33% |
| Net Profit | ₹ 27.27 crs | ₹ 9.57 crs | 184.95% |
| EPS | ₹ 10.91 | ₹ 3.83 | 184.86% |
Financial Results (Year ended FY 20-21) - YoY Comparison
The company has reported total income of Rs.826.40 crores during the 12 months period ended March 31, 2021 as compared to Rs.844.79 crores during the 12 months period ended March 31, 2020.
The company has posted net profit / (loss) of Rs.93.30 crores for the 12 months period ended March 31, 2021 as against net profit / (loss) of Rs.72.22 crores for the 12 months period ended March 31, 2020.
The company has reported EPS of Rs.37.32 for the 12 months period ended March 31, 2021 as compared to Rs.28.89 for the 12 months period ended March 31, 2020.
| Financials | Year Ended FY20-21 | Year Ended FY19-20 | % Change |
| Total Income | ₹ 826.40 crs | ₹ 844.79 crs |  -2.18% |
| Net Profit | ₹ 93.30 crs | ₹ 72.22 crs | 29.19% |
| EPS | ₹ 37.32 | ₹28.89 | 29.18% |
Shares of ASTRAZENECA PHARMA INDIA LTD. was last trading in BSE at Rs.3852 as compared to the previous close of Rs. 3830.45. The total number of shares traded during the day was 4036 in over 984 trades.
The stock hit an intraday high of Rs. 3899.5 and intraday low of 3847.15. The net turnover during the day was Rs. 15631294.
